Average Co-Inventor Count = 5.51
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. H. Lundbeck A/s (39 from 506 patents)
2. Mindimmune Therapeutics, Inc. (2 from 2 patents)
3. Other (1 from 832,680 patents)
4. Leo-pharma A/s (1 from 67 patents)
43 patents:
1. 11851425 - Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines
2. 11634416 - Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines
3. 11535611 - Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors
4. 11491140 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
5. 11472810 - Imidazopyrazinones as PDE1 inhibitors
6. 11104680 - 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors
7. 11026924 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
8. 11026923 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
9. 10912773 - Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors
10. 10905688 - Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitors
11. 10858362 - Imidazopyrazinones as PDE1 inhibitors
12. 10806718 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
13. 10766893 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
14. 10703751 - Amino-imidazopyridine derivatives as Janus kinase inhibitors and pharmaceutical use thereof
15. 10689379 - Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors